ENVESTNET ASSET MANAGEMENT INC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 176 filers reported holding ANTARES PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$79,000
+1.3%
19,231
-11.8%
0.00%
Q4 2021$78,000
+32.2%
21,810
+35.2%
0.00%
Q3 2021$59,000
+9.3%
16,128
+30.4%
0.00%
Q2 2021$54,000
-60.6%
12,367
-78.7%
0.00%
Q1 2020$137,000
-53.1%
58,136
-6.5%
0.00%
Q4 2019$292,000
+65.9%
62,167
+18.5%
0.00%
Q3 2019$176,000
+12.1%
52,478
+10.0%
0.00%
Q2 2019$157,000
+12.9%
47,698
+3.8%
0.00%
Q1 2019$139,00045,9330.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,180,0004.34%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,535,727$11,056,0003.87%
Sargent Investment Group, LLC 3,596,250$15,680,0003.72%
Rubric Capital Management LP 9,500,000$41,420,0002.61%
PERKINS CAPITAL MANAGEMENT INC 541,783$2,362,0001.34%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$8,284,0001.14%
Venator Capital Management Ltd. 709,700$3,094,0001.05%
LEVEL FOUR FINANCIAL, LLC 120,000$523,0000.22%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$875,0000.19%
Brown Advisory Securities, LLC 275,000$1,199,0000.19%
View complete list of ANTARES PHARMA INC shareholders